Relato de caso: primeiro episódio psicótico após infecção por SARS-COV-2
DOI:
https://doi.org/10.25118/2763-9037.2022.v12.400Keywords:
Sars-Cov-2, psychosis, mental health, Covid19 pandemicAbstract
A doença coronavírus 2019 (COVID-19), altamente infecciosa e potencialmente fatal, causada pela nova cepa de Coronavírus SARS-COV-2, tem afetado a população mundial. A psicose é uma síndrome altamente disruptiva com etiologias diversas, caracterizada principalmente por alucinações, delírios, pensamentos e comportamentos desorganizados. O mecanismo pelo qual o COVID-19 pode precipitar a psicose ainda não está completamente esclarecido. Cogita-se o envolvimento de fatores importantes, tais como, o aumento do estresse na vigência da infecção, mediada diretamente pelo vírus ou ainda relacionado ao diagnóstico em si. Este artigo traz o relato de caso de um homem submetido à internação hospitalar na enfermaria de psiquiatria do Hospital das Clínicas da Faculdade de Medicina de Marília, previamente hígido, que desenvolveu o primeiro episódio psicótico após infecção por Sars-Cov-2.
Downloads
Metrics
References
Smith CM, Komisar JR, Mourad A, Kincaid BR. COVID-19-associated brief psychotic disorder. BMJ Case Rep. 2020;13(8):e236940. http://doi.org/10.1136/bcr-2020-236940
Belz M, Hessmann P, Vogelgsang J, Schmidt U, Ruhleder M, Signerski-Krieger J, Radenbach K, Trost S, Schott BH, Wiltfang J, Wolff-Menzler C, Bartels C. Evolution of psychosocial burden and psychiatric symptoms in patients with psychiatric disorders during the Covid-19 pandemic. Eur Arch Psychiatry Clin Neurosci. 2021;3:1–12. http://doi.org/10.1007/s00406-021-01268-6
Lim ST, Janaway B, Costello H, Trip A, Price G. Persistent psychotic symptoms following COVID-19 infection. BJPsych Open. 2020;6(5):e105. http://doi.org/10.1192/bjo.2020.76.
Yao H, Chen JH, Xu YF. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry. 2020;7(4):e21. http://doi.org/10.1016/S2215-0366(20)30090-0.
Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020;87:34-39. http://doi.org/10.1016/j.bbi.2020.04.027.
Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375(6578):267-269. https://10.1126/science.abm2052 - PMID: 35050660
Watson CJ, Thomas RH, Solomon T, Michael BD, Nicholson TR, Pollak TA. COVID-19 and psychosis risk: real or delusional concern? Neurosci Lett. 2021;741:135491. http://doi.org/10.1016/j.neulet.2020.135491
Brown E, Gray R, Lo Monaco S, O'Donoghue B, Nelson B, Thompson A, Francey S, McGorry P. The potential impact of COVID-19 on psychosis: a rapid review of contemporary epidemic and pandemic research. Schizophr Res. 2020;222:79-87. http://doi.org/10.1016/j.schres.2020.05.005.
Ferrando SJ, Klepacz L, Lynch S, Tavakkoli M, Dornbush R, Baharani R, Smolin Y, Bartell A. COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics. 2020;61(5):551-555. http://doi.org/10.1016/j.psym.2020.05.012
Fierini F, Moretti D, Ballerini A. Psychosis spectrum disorders during and after the COVID-19 pandemic: warning signs of "stress incubation". Psychiatry Res. 2020;291:113291. http://doi.org/10.1016/j.psychres.2020.113291
Noone R, Cabassa JA, Gardner L, Schwartz B, Alpert JE, Gabbay V. Letter to the editor: new onset psychosis and mania following COVID-19 infection. J Psychiatr Res. 2020;130:177-179. http://doi.org/10.1016/j.jpsychires.2020.07.042
Rentero D, Juanes A, Losada CP, Álvarez S, Parra A, Santana V, Martí I, Urricelqui J. New-onset psychosis in COVID-19 pandemic: a case series in Madrid. Psychiatry Res. 2020;290:113097. http://doi.org/10.1016/j.psychres.2020.113097.
Parker C, Slan A, Shalev D, Critchfield A. Abrupt late-onset psychosis as a presentation of coronavirus 2019 disease (COVID-19): a longitudinal case report. J Psychiatr Pract. 2021;27(2):131-136. http://doi.org/10.1097/PRA.0000000000000533.
Valdés-Florido MJ, López-Díaz Á, Palermo-Zeballos FJ, Martínez-Molina I, Martín-Gil VE, Crespo-Facorro B, Ruiz-Veguilla M. Reactive psychoses in the context of the COVID-19 pandemic: clinical perspectives from a case series. Rev Psiquiatr Salud Ment (Engl Ed). 2020;13(2):90-94. https://doi.org/10.1016/j.rpsm.2020.04.009 PMID: 32389516 PMCID: PMC7183984
Zhang K, Zhou X, Liu H, Hashimoto K. Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders. Br J Psychiatry. 2020;217(1):351. http://doi.org/10.1192/bjp.2020.84
D Agostino A, D'Angelo S, Giordano B, Cigognini AC, Chirico ML, Redaelli C, Gambini O. Brief psychotic disorder during the national lockdown in Italy: an emerging clinical phenomenon of the COVID-19 pandemic. Schizophr Bull. 2021;47(1):15-22. http://doi.org/10.1093/schbul/sbaa112
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-232. http://doi.org/10.1016/S0140-6736(20)32656-8
Parra A, Juanes A, Losada CP, Álvarez-Sesmero S, Santana VD, Martí I, Urricelqui J, Rentero, D. Psychotic symptoms in COVID-19 patients. A retrospective descriptive study. Psychiatry Research. 2020;291,113254. https://doi.org/10.1016/j.psychres.2020.113254
Correa-Palacio, AF, Hernandez-Huerta D, Gómez-Arnau J, Loeck C, Caballero, I. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report. Psychiatry Research. 2020;290,113115. https://doi.org/10.1016/j.psychres.2020.113115
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License
Copyright (c) 2022 Fellipe Oliveira Melo, Juliane de Souza Cavazzana, Vivian Fernanda Amaral
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
